Register
Login:
Share:
Email Facebook Twitter

Share Views: HUM CEO updates on Yanfolila and Dugbe Gold Projects. Watch here

Share Views Ep. 19
HUM CEO updates on Yanfolila and Dugbe Gold Projects.


Sareum Share Chat (SAR)



Share Price: 0.80Bid: 0.75Ask: 0.85Change: 0.00 (0.00%)No Movement on Sareum
Spread: 0.10Spread as %: 13.33%Open: 0.80High: 0.80Low: 0.80Yesterday’s Close: 0.80


Share Discussion for Sareum


Thread View

Please login or register to post a message on Share Chat.

Posts per page:


Supergut
Posts: 79
Off Topic
Opinion:No Opinion
Price:0.80
RE: big month
Today 01:02
just checked adv and I think we've found the identity of Thoth's shorter. Dude sounds desperate. That 200dma is going to prove a real tough cookie, I'd be desperate too if I was short.
 
getcarter
Posts: 6,517
Off Topic
Opinion:No Opinion
Price:0.80
Silver
Today 00:44
Who gives a 4x on your opinion, I've made mine and it's none of your business where I choose to invest. Jog on
Silvergreyhead
Posts: 104
Off Topic
Opinion:No Opinion
Price:0.80
RE: big month
Today 00:36
For F..s sake grow up the lot of you this is going nowhere. It is not being played by the MM s it is not being eyed up by big Phizas and it sure ain't going to get to 5 let alone 28 a share its boll..ckz and crap look at advinz
Borg
Posts: 152
Off Topic
Opinion:Strong Buy
Price:0.80
Nimbus Pushing Hard with the PR
Sat 21:41
Today #ASH16 Nimbus’ DFCI collaborators present data on the selective Tyk2 inhibitor, NDI-031301, in T-ALL ash.confex.com/ash/2016/webpr…

Wonder if they are aware that we (SAR) are ahead of them on T-All research
Mr_Jay
Posts: 1,485
Off Topic
Opinion:No Opinion
Price:0.80
RE: big month
Sat 18:09
Hahaha possible takeover? Where did the possible come from? R we expecting a possible takeover of £10billion?
greenmile
Posts: 643
Off Topic
Opinion:No Opinion
Price:0.80
big month
Sat 17:58
ahead news flow and possible takeover
Thoth2
Posts: 1,149
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.80
View Thread (4)
Notes
Sat 00:55
I don't think we have a floor until an institutional is on board.
We do have an end date though so vc capital may have a look.
I have discounted aurora. It's a bonus when if it happens.
Chk1 will.pass p1 end 2017. 10m milestone guess. P2 end 2018 20m milestone when dnai will on licence it. And we will get a cut.
Tyk2 is interesting. It's a variable thermostat. Cancer drugs it's maximum dose before side effects. Autoimmune it's getting the temperature just right. Just the right amount which depends on the disease and the patient.
Which is going to take longer. More compounds. More preclinical. More trials. The good news is. Currently incurable diseases. As big as cancer market. Lifelong medicines. And despite the billions spent we appear to have the best in class molecules. So short term who knows. But 2 years I'm expecting full value and in the meantime a poacher may see the same. I personally think 2 big pharma are looking at tyk2 atm. But no hard facts just reading between the lines. Gla
moons
Posts: 2,803
Off Topic
Opinion:No Opinion
Price:0.80
Closing the thread
Fri 17:03
No need for fall outs

I wish all a very nice weekend.
bp82
Posts: 449
Off Topic
Opinion:No Opinion
Price:0.80
Thoth
Fri 16:16
Given all goes ok and no further deal arrives, where do you see the SP
mangio61
Posts: 2,208
Off Topic
Opinion:No Opinion
Price:0.80
RE: Thoth2
Fri 14:48
look fwd to seeing it :-) then you should be able to see my top up ;)




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.